Variations in Apolipoproteins Serum Amyloid A, A-I, A-II, and C-III in Severely Head-Injured Patients

In five severely head-injured patients we determined the plasma concentrations of apolipoproteins serum amyloid A, A-I, A-II, C-III, and B, prealbumin and C-reactive protein on day 1, 5, 10 and 15 after head injury where possible. A dramatic increase in apolipoprotein serum amyloid A up to a mean plasma level of 0.764 g/l was accompanied by a considerable decrease in apolipoprotein A-I, apolipoprotein A-II and apolipoprotein C-III concentrations. The variations observed by immunological methods were confirmed by two-dimensional gel electrophoresis performed on plasma and different lipoprotein fractions. In addition to its association with high density lipoproteins, apolipoprotein serum amyloid A was also found with lipoproteins of low and very low density. Two-dimensional electrophoresis also showed the presence of several different serum amyloid A-peptides not seen in plasmas from healthy subjects. We propose that apolipoprotein serum amyloid A may be responsible for the decrease of the main HDL apolipoproteins in head-injured patients.

[1]  M. Mccarty.  Historical Perspective on C‐Reactive Protein , 1982, Annals of the New York Academy of Sciences.

[2]  A. Husebekk,et al.  Characterization of Amyloid Proteins AA and SAA as Apolipoproteins of High Density Lipoprotein (HDL) , 1987, Scandinavian journal of immunology.

[3]  H. Colten,et al.  Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. , 1985, Biochemistry.

[4]  K. Sletten,et al.  Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA). , 1982, Clinical and experimental immunology.

[5]  G. Hocke,et al.  Enzyme-linked immunosorbent assay for serum amyloid A apolipoprotein with use of specific antibodies against synthetic peptides. , 1988, Clinical chemistry.

[6]  M. Skinner,et al.  THE ROLE OF INTERLEUKIN 1 IN ACUTE PHASE SERUM AMYLOID A (SAA) AND SERUM AMYLOID P (SAP) BIOSYNTHESIS * , 1982, Annals of the New York Academy of Sciences.

[7]  P. Barter,et al.  Appearance of serum amyloid protein in high-density lipoproteins of rabbits subjected to relatively mild stimuli. , 1984, Biochimica et biophysica acta.

[8]  B. Hazenberg,et al.  The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. , 1988, Biochemical and biophysical research communications.

[9]  J. Sipe,et al.  Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. , 1978, The Journal of clinical investigation.

[10]  H. Baumann,et al.  Synthesis and regulation of acute phase plasma proteins in primary cultures of mouse hepatocytes , 1983, Journal of Cell Biology.

[11]  P. Heinrich,et al.  Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes , 1989, FEBS letters.

[12]  M. Benson,et al.  Amino acid structures of multiple forms of amyloid-related serum protein SAA from a single individual. , 1988, Biochemistry.

[13]  G. Coetzee,et al.  Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. , 1986, The Journal of biological chemistry.

[14]  H. Brewer,et al.  Two-dimensional electrophoresis of human plasma apolipoproteins. , 1984, Clinical chemistry.

[15]  K. Frei,et al.  [Interleukin 1]. , 1985, Schweizerische medizinische Wochenschrift.

[16]  K. Titani,et al.  Amino acid sequence of amyloid-related apoprotein (apoSAA1) from human high-density lipoprotein. , 1982, Biochemistry.

[17]  H. Colten,et al.  Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1 , 1985, The Journal of experimental medicine.

[18]  C. Malmendier,et al.  Separation and partial characterization of new apoproteins from human plasma high density lipoproteins. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[19]  L. Bausserman,et al.  Serum amyloid A and high density lipoproteins during the acute phase response , 1988, European journal of clinical investigation.

[20]  J. Sipe.  Induction of the acute-phase serum protein SAA requires both RNA and protein synthesis. , 1978, British journal of experimental pathology.

[21]  M. Pepys,et al.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. , 1983, Advances in immunology.

[22]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[23]  J. Parks,et al.  Metabolism of the serum amyloid A proteins (SSA) in high-density lipoproteins and chylomicrons of nonhuman primates (vervet monkey). , 1983, The American journal of pathology.

[24]  P. Métais,et al.  Evaluation of immunonephelometry of C-reactive protein in serum. , 1980, Clinical chemistry.

[25]  L. Bausserman,et al.  NH2-terminal analysis of four of the polymorphic forms of human serum amyloid A proteins. , 1982, Biochimica et biophysica acta.

[26]  Sipe Jd.  Induction of the acute-phase serum protein SAA requires both RNA and protein synthesis. , 1978 .

[27]  H. Colten,et al.  Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. , 1986, The Journal of clinical investigation.

[28]  J. Volanakis,et al.  C-reactive protein and the plasma protein response to tissue injury. , 1982, Annals of the New York Academy of Sciences.

[29]  G. Férard,et al.  Immunonephelometric determination of prealbumin in serum of newborns. , 1985, Clinical chemistry.

[30]  N. Eriksen,et al.  Amyloid protein SAA is associated with high density lipoprotein from human serum. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[31]  I. Kushner,et al.  C-reactive protein and the acute-phase response. , 1990, Hospital practice.

[32]  M. Kaplan,et al.  THE BIOLOGY OF SAA: IDENTIFICATION OF THE INDUCER, IN VITRO SYNTHESIS, AND HETEROGENEITY DEMONSTRATED WITH MONOCLONAL ANTIBODIES * , 1982, Annals of the New York Academy of Sciences.

[33]  N G Anderson,et al.  High resolution two-dimensional electrophoresis of human plasma proteins. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. J. Stewart,et al.  A micromethod for the emergency estimation of plasma paracetamol concentration using high performance liquid chromatography. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[35]  N. Eriksen,et al.  Trauma, high density lipoproteins, and serum amyloid protein A. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[36]  L. Bausserman,et al.  Heterogeneity of human serum amyloid A proteins , 1980, The Journal of experimental medicine.

[37]  R. Stearman,et al.  Transcriptional regulation of serum amyloid A gene expression. , 1986, The Journal of biological chemistry.

[38]  L. Bausserman,et al.  Degradation of serum amyloid A by isolated perfused rat liver. , 1987, The Journal of biological chemistry.

[39]  R. Klausner,et al.  Interaction of the serum amyloid A proteins with phospholipid. , 1983, The Journal of biological chemistry.

[40]  N. Eriksen,et al.  Isolation and characterization of the amyloid-related apoprotein (SAA) from human high density lipoprotein. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Sabesin,et al.  Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. , 1989, Journal of lipid research.

[42]  C. Malmendier,et al.  Apoprotein S, a family of human serum lipoprotein polypeptides. , 1982, Atherosclerosis.

[43]  C. Fiévet,et al.  Quantification of apolipoprotein C-III in serum by a noncompetitive immunoenzymometric assay. , 1985, Clinical chemistry.

[44]  L. Bausserman,et al.  Serum amyloid A polymorphism in a subject with a naturally occurring inflammatory response. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[45]  E. Benditt,et al.  Formation of serum amyloid (aposaa)-rich hdl subfractions following endotoxin administration in the mouse. Abstr. , 1982 .

[46]  C. Malmendier,et al.  Partial amino acid sequence of three new apolipoproteins isolated from human high density lipoproteins , 1980, FEBS letters.

[47]  P. Clifton,et al.  Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. , 1985, Journal of lipid research.

[48]  Y. Moschetto,et al.  Simultaneous measurement of plasma apolipoproteins A-I and B by electroimmunoassay. , 1982, Clinical chemistry.

[49]  A. Scanu,et al.  On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. Effect of concentration and molecular forms of apolipoprotein A-II. , 1982, The Journal of biological chemistry.

[50]  C. Malmendier,et al.  In vivo metabolism of apolipoprotein S in humans. Comparison with apolipoprotein A-I metabolism. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[51]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[52]  C. V. van Veelen,et al.  Isoenzymes of creatine kinase in extracts of various parts and regions of the human central nervous system. , 1980, Clinical chemistry.

[53]  M. Kaplan,et al.  Monokine-induced synthesis of serum amyloid A protein by hepatocytes , 1980, Nature.

[54]  E. Benditt,et al.  Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance. , 1983, The Journal of clinical investigation.